The objective of this review is to summarise the available evidence on the frequency and
management of incidental findings in imaging diagnostic tests. Original articles were …

Multimodality imaging, as represented by its greatest exponent, PET/CT, has a firm place in
the evaluation of a patient presenting with cancer. With 18F-FDG, PET/CT is rapidly …

Functional imaging with positron emission tomography (PET) is playing an increasingly
important role in the diagnosis and staging of malignant disease, image-guided therapy …

PET/CT with 18 F-FDG is increasingly being used for staging, restaging, and treatment
monitoring for cancer patients. CT is still frequently used only for attenuation correction and …

Screening for cancer remains a very emotional and hotly debated issue in contemporary
medical practice. An analysis of published data reveals a multitude of opinions based on a …

The gastrointestinal (GI) tract is not a common site of metastasis in primary lung cancer. The
aim of the present study was to reveal the clinical and prognostic characteristics of …

Abstract Background: 18Fluoro‐2‐deoxyglucose (18FDG) positron emission tomography
(PET) is widely used for initial staging and follow‐up in patients with malignant lymphoma …

A routine feature of positron emission tomography/computed tomography (PET/CT) imaging
is whole-body acquisition that results in many unexpected findings identified outside of the …

ContextStaging of patients with colorectal cancer often requires a multimodality, multistep
imaging approach. Colonography composed of a combined modality of positron emission …

Positron emission tomography (PET) with 2-[fluorine-18] fluoro-2-deoxy-d-glucose (FDG)
has been shown to be sensitive in the detection of many bowel malignancies, but its …